Interstitial Lung Diseases
Respiratory Critical Care
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
ERJ Open Research
European Lung White Book
All ERS guidelines
Global Lung Function Initiative
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
Courses and events
A nocturnal temperature controlled laminar flow device (TLA) maintains good control of severe allergic asthma (SAA) after withdrawal of Omalizumab therapy
C. Wang (Taoyuan, Taiwan), C. Lo (Taoyuan, Taiwan), H. Kuo (Taoyuan, Taiwan)
International Congress 2018 – Asthma management
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
C. Wang (Taoyuan, Taiwan), C. Lo (Taoyuan, Taiwan), H. Kuo (Taoyuan, Taiwan). A nocturnal temperature controlled laminar flow device (TLA) maintains good control of severe allergic asthma (SAA) after withdrawal of Omalizumab therapy. 1694
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
No comment yet.
to comment this presentation.
Related content which might interest you:
Diagnosis and treatment of chronic pulmonary embolism
Prevention of pleural infection
Is it possible to prevent bronchiectasisand its flares?